A Kaposi's sarcoma complete clinical response after sorafenib administration

Ann Oncol. 2008 Sep;19(9):1658-9. doi: 10.1093/annonc/mdn528. Epub 2008 Jul 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzenesulfonates / administration & dosage*
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / secondary*
  • Carcinoma, Renal Cell / surgery
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Kidney Neoplasms / pathology*
  • Kidney Neoplasms / surgery
  • Male
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Protein Kinase Inhibitors / administration & dosage*
  • Pyridines / administration & dosage*
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / secondary
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / secondary
  • Sorafenib
  • Treatment Outcome

Substances

  • Benzenesulfonates
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Pyridines
  • Niacinamide
  • Sorafenib